Online Enquiry
Subscribe
Log in / New User
Retrieve Password
此页面上的内容需要较新版本的 Adobe Flash Player。
切换导航
Home
Pharma China Web Edition
Pharma China Archives
Online Databases
Subscription/Download
Event Calendar
China Pharma Providers
About Us
Location:
Home
News
The Market
Industry News
Regulatory News
General Health
Legal/IPR News
Product/R&D News
API/Bulk Drug News
People in the News
Other News
Top News Worldwide
Feature articles
Editorials
Focus Articles
Expert Opinions
Interviews
Case Studies
Company Profiles
Editor's Picks
Full Text
Title
Subscribe to Pharma China
Online Enquiry
The Market
Industry News
Regulatory News
General Health
Legal/IPR News
Product/R&D News
API/Bulk Drug News
People in the News
Other News
Top News Worldwide
Editorials
Focus Articles
Expert Opinions
Interviews
Case Studies
Company Profiles
Editor's Picks
ONLINE ENQUIRY
WiCON International Group
Bellevue, WA 98007, USA
info@pharmachinaonline.com
WiCON International Co. Ltd.
Osaka, Japan
info@pharmachinaonline.com
Relate News
12/2/2024
UCB Closes Divestment from Neurology and Allergy Portfolio in China, ...
11/29/2024
Recent Executive Moves
11/28/2024
NHSA Issues Guidelines for Managing Pricing Risks of Shortage Drugs
11/28/2024
NHSA and MOHRSS Announce the 2024 National Drug Reimbursement List
11/28/2024
NMPA Solicits Public Comments on the Provisions for the Record Filing ...
11/28/2024
BeOne Secures EU Approval for First-Line Checkpoint Blocker
11/27/2024
ChP Commission Approves Chinese Pharmacopeia 2025
11/27/2024
Kelun's Merck-partnered TROP2 ADC sac-TMT Approved for Marketing in C...
11/27/2024
NMPA Accepts Akeso's sNDA for Penpulimab Plus Anlotinib for Advanced H...
11/27/2024
CMS's CMS-D005 Gets Green Light for Its Obesity Drug Trials in China
11/27/2024
NHSA: Policies in Development to Synchronize Medical Insurance Funds a...
11/27/2024
China Introduces New Policy to Strengthen Hierarchical Medical Care an...
11/27/2024
Asian Market Rattled by Trump Tariffs: Yang Report (LinkedIn)
11/26/2024
Snapshot of BMI System Financial Performance in 3Qs/2024
11/22/2024
Hua Medicine to Terminate China Commercialization Agreement with Bayer...
11/22/2024
NHC Issues the Opinions on Reforming and Improving the Grassroots Drug...
11/22/2024
Recent Executive Moves
11/21/2024
CStone and Pharmalink Enter into Strategic Partnership for Sugemalimab...
11/21/2024
Merck's Belzutifan Approved in China for VHL Disease-Associated Tumors
11/21/2024
RDPAC Reinforces Strategic Commitment to China's Pharmaceutical Market
11/21/2024
Sino Biopharma Strengthens Oncology Portfolio with Investment in LaNov...
11/20/2024
FDA Issues Warning to Tianjin Darentang for Manufacturing and Transpar...
11/20/2024
J&J and Merck Restructure Operations in China Amid Market Challenges
11/20/2024
Probe of AstraZeneca Executive in China Raises Questions About Company...
11/20/2024
Promoting Collaboration in Regional Healthcare Systems in Hong Kong, ...
11/19/2024
Congress Debates Biosecure Act Amid Report Highlighting Misaligned Foc...
11/18/2024
Chengdu Keymed Licenses BCMAxCD3 Bispecific Antibody to Platina Medici...
11/18/2024
Junshi Biosciences Announces UK MHRA Approval for Marketing of Toripal...
11/18/2024
WuXi AppTec Opens New R&D Center in Changzhou
11/18/2024
IMPACT Thera Raises $34M in Series D++ Funding to Advance PARP Inhibit...
Page:
13
/
354
Total number of articles:
10618
:
[First]
[<<]
[11]
[12]
[13]
[14]
[15]
[>>]
[End]
News
The Market
Industry News
Regulatory News
General Health
Legal/IPR News
Product/R&D News
API/Bulk Drug News
People in the News
Other News
Top News Worldwide
FEATURE ARTICLES
Editorials
Focus Articles
Expert Opinions
Interviews
Case Studies
Company Profiles
Editor's Picks
GENERAL INFORMATION
TERMS & CONDITIONS OF USE
Download Info
Contact Us
Site map
|
Contact Us
|
Links
© Wicon International Group
×
Join the mailing list
We will e-mail you the most critical news and developments about China's healthcare sector, in real time and absolutely free.
name:
e-mail:
company:
submit